Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Barinthus Biotherapeutics (BRNS) Shares Outstanding (Weighted Average) (2020 - 2026)

Barinthus Biotherapeutics filings provide 7 years of Shares Outstanding (Weighted Average) readings, the most recent being $40.8 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 1.45% to $40.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $40.8 million, a 1.45% increase, with the full-year FY2025 number at $40.5 million, up 3.0% from a year prior.
  • Shares Outstanding (Weighted Average) hit $40.8 million in Q1 2026 for Barinthus Biotherapeutics, up from $40.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $40.8 million in Q1 2026 to a low of $37.2 million in Q1 2022.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $38.8 million (2024), compared with a mean of $38.9 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): surged 361.59% in 2022 and later rose 1.45% in 2026.
  • Barinthus Biotherapeutics' Shares Outstanding (Weighted Average) stood at $37.2 million in 2022, then increased by 3.06% to $38.4 million in 2023, then grew by 2.51% to $39.3 million in 2024, then increased by 3.0% to $40.5 million in 2025, then grew by 0.79% to $40.8 million in 2026.
  • The last three reported values for Shares Outstanding (Weighted Average) were $40.8 million (Q1 2026), $40.5 million (Q4 2025), and $40.4 million (Q3 2025) per Business Quant data.